Ignite Creation Date:
2024-05-06 @ 3:30 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04654520
Status:
UNKNOWN
Last Update Posted:
2020-12-04
First Post:
2020-11-29
Brief Title:
A Randomized Study of Primary Tumor Radiotherapy for Patients With Stage Ⅳ NSCLC
Sponsor:
Guizhou Medical University
Organization:
Guizhou Medical University
Study Overview
Official Title:
A Randomized Study of Primary Tumor Radiotherapy Omitting Clinical Target Volume for Patients With Stage Ⅳ NSCLC
Status:
UNKNOWN
Status Verified Date:
2020-11
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this randomized study is to investigate local tumor control survival outcomesand complications on patients of stage Ⅳ non small-cell lung cancer whom based on medication with concurrent primary radiotherapy omitting clinical tumor volume
Detailed Description:
Cancer Statistics2020states that low lung cancer survival rates reflect the large proportion of patients 57 diagnosed with metastatic disease for which the 5-year relative survival rate is 5With the development of three-dimensional radiotherapy technology the wide application of comprehensive treatment concept and the understanding of the relationship between different metastatic state and survival of stage IV NSCLC prospective and retrospective studies have confirmed that systemic therapy combined with primary tumor three-dimensional radiation Treatment is more conducive to improving symptoms and prolonging survival than medication alone Some retrospective analysises of stage III NSCLC omitting clinical target volume of primary tumor with intensity modulated radiotherapy showed no reduction in local control rate and survival timeOmitted CTV in Ⅳ NSCLC patients with primary tumor radiotherapy can make smaller target area which could push up most of the local stage of late Ⅳ NSCLC patients with primary tumor radiation dose Prospective studies are needed to further clarify whether omission of target areas may affect local control time survival time and radioactive toxicity
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None